Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
9,010
-365
-4% -$42.7K 0.79% 29
2026
Q1
$1.13M Sell
9,375
-653
-7% -$75.4K 0.87% 24
2025
Q4
$1.06M Sell
10,028
-2,626
-21% -$247K 0.79% 27
2025
Q3
$1.06M Buy
12,654
+12,091
+2,148% +$996K 0.83% 35
2025
Q2
$44.6K Sell
563
-10,185
-95% -$810K 0.03% 86
2025
Q1
$965K Buy
10,748
+1,356
+14% +$127K 0.89% 31
2024
Q4
$912K Buy
+9,392
New +$968K 0.91% 25

Other funds holding MRK

Winnow Wealth's MRK Position: Q2 2026 in Review

Winnow Wealth reduced its Merck (MRK) stake by 3.9% in Q2 2026, selling an estimated $42.7K and leaving 9,010 shares worth $1.16M. The position accounts for 0.79% of the portfolio, ranked #29.

Winnow Wealth first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Winnow Wealth held 9,010 shares of Merck worth $1.16M as of Q2 2026.
  • Winnow Wealth sold 365 Merck shares in Q2 2026, an estimated $42.7K.
  • Merck made up 0.79% of Winnow Wealth's portfolio in Q2 2026, its #29 holding.
  • Winnow Wealth first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Winnow Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.